In their study on tissue specimens, Artemaki et al. [50] showed that patients with significantly higher levels of CLU mRNA in tumors were at higher risk of recurrence or death and that the expression of CLU mRNA increased together with tumor growth and disease progression. The gene discussed is CLU; the disease is neoplasm.